Nursing Economics, published by Jannetti Publications, Inc, is a significant peer-reviewed journal that serves the nuanced intersection of healthcare economics and nursing. Operating under ISSN 0746-1739, this esteemed journal has been instrumental in advancing knowledge within the nursing profession since its inception in 1983, although its coverage was discontinued in Scopus as of 2021. With a focus on innovative research and practical applications, Nursing Economics addresses key issues in leadership and management within the nursing field, holding a Q3 quartile ranking in both Leadership and Management and Medicine (miscellaneous) as of 2023. Its Scopus rank within nursing leadership and management indicates a respectable position among its peers, demonstrating its relevance and contribution to the professional discourse. Researchers, practitioners, and students alike will find valuable insights and evidence-based perspectives that aim to enhance the practice and study of nursing economics in today’s evolving healthcare landscape.

Global & Regional Health Technology Assessment (ISSN: 2284-2403; E-ISSN: 2283-5733) is an esteemed open-access journal published by ABOUTSCIENCE SRL, dedicated to the dissemination of research in the field of health technology assessment on a global and regional scale. Since its inception in 2014, this journal has focused on the critical evaluation of health technologies, providing invaluable insights into their efficacy, cost-effectiveness, and impact on healthcare systems. With an increasing emphasis on public health and policy implications, the journal encourages interdisciplinary research that bridges gaps between technological innovations and health outcomes. Despite its relatively recent establishment, it has made significant inroads with Scopus rankings reflecting the growing importance of health technology assessment in global health discourse. The journal welcomes contributions from researchers, professionals, and students, inviting them to engage in discussions that shape the future of health technology, with the aim of informing stakeholders and policymakers worldwide.

The American Journal of Health Economics is a premier academic publication dedicated to advancing the understanding of the economic aspects of health and healthcare. Published by the University of Chicago Press, this journal has established itself as a vital resource for researchers, policymakers, and health professionals since its convergence in 2015. With an impressive Q1 ranking in key categories—including Economics, Health Policy, and Public Health—and a solid reputation in the academic community, it ranks in the top 20% for Economics and Health Policy in the Scopus database. The journal seeks to publish high-quality, peer-reviewed articles that contribute to the discourse on health economics, addressing critical issues like health disparities, policy evaluation, and the efficiency of healthcare systems. Although it does not offer open access, subscribers can access groundbreaking research that shapes health economic strategies and practices. As a trusted source in its field, the American Journal of Health Economics plays a crucial role in fostering evidence-based decision-making and enhancing the impact of economic research in healthcare.

Health Services Management Research is a premier academic journal published by SAGE PUBLICATIONS LTD, focusing on critical areas within the health policy domain. With an ISSN of 0951-4848 and E-ISSN 1758-1044, this UK-based journal has been a valuable resource for over three decades, converging from 1988 to 2024. Recognized for its contribution to the field, it holds a commendable Q2 quartile ranking, positioning it in the top 35% of journals in Health Policy, reflecting its significant impact within the academic community, as evidenced by its rank of 109 out of 310 in Scopus rankings, placing it in the 65th percentile. The journal aims to foster innovative research that addresses the complexities of health services management, making it an indispensable resource for researchers, professionals, and students dedicated to improving health systems. Although it currently does not offer Open Access, the journal remains committed to advancing knowledge and practice in health policy management through rigorous peer-reviewed articles, case studies, and evidence-based analyses.

The Journal of Managed Care & Specialty Pharmacy is a premier publication in the realm of health policy and pharmaceutical science, dedicated to enhancing the understanding and practices surrounding managed care systems and specialty medications. Published by ACAD MANAGED CARE PHARMACY, this journal boasts an impressive Q1 ranking in both Pharmaceutical Science and Pharmacy, underscoring its significance in advancing professional discourse and research in these critical areas. With a focus on innovative care strategies and patient-centered approaches, it aims to share impactful research, reviews, and opinions that shape the future of health policy and pharmaceutical practices. The journal is available in an open access format, ensuring that vital information is universally accessible to researchers, practitioners, and policymakers alike. With its inception in 2014 and an ongoing commitment to excellence through 2024, the journal is firmly established as a leading resource within its field, making it essential reading for professionals dedicated to improving managed care and specialty pharmacy solutions.

The European Journal of Health Economics, published by SPRINGER, is a premier interdisciplinary journal dedicated to advancing research in the intersection of health policy and economic theory. With an impressive impact factor and consistently ranked in the Q1 category in both Economics and Health Policy (2023), this journal serves as a vital platform for disseminating innovative research findings and practical insights relevant to today's healthcare challenges. Covering a broad spectrum of topics, from health care financing and economic evaluation to policy analysis, the journal aims to foster dialogue among academics, policymakers, and practitioners alike. Published continuously from 2002 to 2024, the European Journal of Health Economics holds its rank within the top 12% of Economics and Finance journals and the top 16% in Medicine. Researchers and students looking to stay abreast of the latest trends and methodologies in health economics will find this journal an invaluable resource.

Health Policy OPEN is an esteemed open-access journal published by Elsevier that has made significant contributions to the field of health policy since its inception in 2020. With an impact factor placing it in the prestigious Q2 category of health policy journals, it ranks 116 out of 310 within the Scopus database, highlighting its critical engagement in the field and situating it within the 62nd percentile. As an open-access platform, Health Policy OPEN promotes the dissemination of high-quality research, making it accessible to a global audience of researchers, professionals, and students alike. The journal focuses on topical issues, innovative approaches, and evidence-based practices that shape health policies worldwide. With its headquarters in Amsterdam, Netherlands, the journal serves as a vital resource for advancing knowledge and fostering discussions that drive health policy initiatives and reforms. Engage with Health Policy OPEN to contribute to the evolving landscape of health policy and to stay informed on the latest research advancements.

PHARMACOECONOMICS, published by ADIS INT LTD, is a prestigious international journal dedicated to disseminating research in the fields of health policy, pharmacology, and public health. With an impressive impact factor and a solid Q1 ranking across its relevant categories, this journal plays a crucial role in shaping policy decisions, optimizing health resources, and enhancing pharmacoeconomic evaluations globally. The journal not only targets researchers and professionals but also serves as an invaluable resource for students striving to understand the economic implications of pharmaceutical care. Operating since 1992 and continuously evolving through 2024, PHARMACOECONOMICS invites contributions that address the complexities of drug expenditure, health outcomes, and public health implications, thereby fostering informed decision-making in healthcare systems. Readers can explore cutting-edge studies and analyses aimed at balancing cost-effectiveness with clinical effectiveness, making this journal a cornerstone for stakeholders invested in the future of health economics.

Farmeconomia-Health Economics and Therapeutic Pathways is a pioneering journal within the field of health economics, dedicated to exploring the intersections of health policy, therapeutics, and economic evaluations. Published by SEED MEDICAL PUBLISHERS, this Open Access journal has been at the forefront of advancing knowledge since 2012, ensuring that vital research is readily accessible to a global audience without subscription barriers. The journal aims to facilitate the dissemination of insightful studies, systematic reviews, and theoretical discussions that determine the cost-effectiveness of therapeutic options, ultimately guiding evidence-based healthcare decisions. Based in *Torino, Italy*, this journal is committed to serving researchers, healthcare professionals, and students who are eager to contribute to and stay updated on the latest developments in health economics and policy implementation. With its broad-ranging scope and dedication to quality research, Farmeconomia stands as an essential resource for anyone engaged in the complex dynamics of health systems and their economic implications.

Allergy Asthma and Clinical Immunology, a pioneering open access journal published by BMC, has been at the forefront of immunological research since its inception in 2005. With an ISSN of 1710-1492, this UK-based journal has established a significant presence in the fields of Immunology, Allergy, and Pulmonary and Respiratory Medicine, achieving notable quartile rankings such as Q2 in Immunology and Allergy in 2023. It plays a crucial role in disseminating high-quality research that advances our understanding of allergy and asthma, making substantial contributions to clinical practices and public health. The journal embraces the principles of Open Access, allowing researchers, professionals, and students from around the globe to access its content freely, thus facilitating knowledge sharing and collaboration within the scientific community. As it converges towards 2024, Allergy Asthma and Clinical Immunology continues to attract impactful studies that drive innovation and improve patient care in the face of rapidly evolving challenges in immunological health.